S
LIVE

Serial Number

87083379

Owner

SURMODICS, INC.

Attorney

Scott Johnston

Filing Date

Jun 24, 2016

Add to watchlist:

No watchlists yet
View on USPTO

S Trademark

Serial Number: 87083379 • Registration: 6283275

S is a trademark filed by SURMODICS, INC. on June 24, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

SURMODICS, INC. (66 trademarks)

9924 WEST 74TH STREET
EDEN PRAIRIE, MN 55344

Entity Type: 03

Trademark Details

Filing Date

June 24, 2016

Registration Date

March 2, 2021

Published for Opposition

November 29, 2016

Goods & Services

Surface treatment services for stabilizing proteins upon enzyme immunoassay product components of others

Microarray slides for scientific, laboratory or medical research use; beads, membranes, plates and surfaces for scientific research use; customizable polymer surfaces that immobilize or attach target biomolecules to the surface while preventing adsorption of unwanted biomolecules to the surface, sold as an integral component of all the aforesaid goods

Chemical preparations for medical purposes, namely, for coating medical devices and delivering medicine for the treatment of vascular disease; Drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; cell and tissue delivery matrices consisting of compounds that facilitate delivery of cells and tissue to the body; naturally biodegradable matrix used as a carrier for pharmaceuticals, cells and tissue; Chemical reagents for medical or veterinary purposes

Reagents for scientific or medical research use; Photoreactive chemical coating compositions for industrial, including medical, use; Chemicals for use in the manufacture of medical device coatings; Chemical preparations for scientific purposes used for blocking and antibody dilution in blotting applications; chemical preparations for scientific purposes for use with analytical procedures in research and diagnostic applications; Liquid preparation for use in stabilizing reagents employed in immunoassays; Chemical solutions for stabilizing biological molecules for scientific or medical research use and for use in the manufacture of medical devices; Chemicals, namely, a chemical solution for use in preserving analytical reagents for scientific and research use; Photoreactive chemical coating compositions for general industrial use, and for use in the manufacture of medical devices and diagnostic test devices; Diagnostic assay kits composed primarily of DNA assay substrates and reagents; diagnostic assay components, namely, DNA assay substrates and reagents; Chemicals for use in the manufacture of coatings for medical devices; chemicals for use in the manufacture of drug eluting coatings; chemicals for use in the manufacture of drug delivery coatings; Biopolymer based coatings for use in the manufacture of implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices

Medical devices and apparatus, namely, catheters and drug eluting balloon catheters; Medical devices, namely, stents that contain and deliver a wide range of pharmaceuticals; coatings for orthopedic implants, ocular implants and surgical implants comprised of artificial materials, sold as an integral part of the implants, for the delivery of a wide range of pharmaceuticals; Coatings sold as an integral component of medical stents and other implantable medical devices, namely, coatings containing extracellular matrix proteins designed to improve and accelerate tissue healing of implantable medical devices; Medical devices, namely, coronary stent systems; Medical devices, namely, angioplasty catheters; Medical devices, namely, medical device Access systems; Medical devices, namely, chronic total occlusion devices; Medical devices, namely, embolic protection device; Medical devices, namely, hemostasis introducer sheath; Medical devices, namely, interventional micro-catheter

Research and development services in the field of chemical analysis tests and procedures; Research and development of new products for others in the fields of pharmaceuticals and medical and surgical devices; scientific and research consultation and product research in the fields of pharmaceuticals and medical and surgical devices; product development consultation in the fields of pharmaceuticals and medical and surgical devices; scientific and research consulting in the field of medical devices and medical device coatings and medical device drug delivery systems; scientific and research consulting in the fields of conducting medical pre-clinical studies and clinical trials; consulting in the field of quality control for medical devices and testing for quality control; Custom design of medical device coatings for others; Testing services for medical devices and medical device coatings; medical device testing for Durability, Shelf-life, aging studies process reproducibility, coating morphology consistency, Defect analysis, impurities, contaminants, drug release mechanisms; diagnostic services in the field of medical devices and coatings; Consulting in the field of medical devices related to design and development of coaxial guide catheter

Filing History

EXPARTE APPEAL TERMINATED
Mar 4, 2021 EXPT
REGISTERED-PRINCIPAL REGISTER
Mar 2, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 28, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 27, 2021 CNPR
EXAMINER'S AMENDMENT ENTERED
Jan 27, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 27, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 27, 2021 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Jan 27, 2021 SNEA
EX PARTE APPEAL-INSTITUTED
Dec 19, 2020 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Dec 19, 2020 JURT
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 7, 2020 ERFR
EXPARTE APPEAL RECEIVED AT TTAB
Dec 7, 2020 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 6, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 6, 2020 GNFR
SU - FINAL REFUSAL - WRITTEN
Jun 6, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2020 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 6, 2020 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jan 28, 2020 SUPC
USE AMENDMENT FILED
Jan 23, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 23, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 23, 2019 EXRA
SOU EXTENSION 5 GRANTED
Jul 22, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 22, 2019 AITU
SOU EXTENSION 5 FILED
Jul 17, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Jul 17, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jan 24, 2019 EX4G
SOU EXTENSION 4 FILED
Jan 24, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jan 24, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 26, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jul 24, 2018 EX3G
SOU EXTENSION 3 FILED
Jul 24, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 24, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 25, 2018 EXRA
SOU EXTENSION 2 GRANTED
Jan 23, 2018 EX2G
SOU EXTENSION 2 FILED
Jan 23, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 23, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 21, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jul 19, 2017 EX1G
SOU EXTENSION 1 FILED
Jul 19, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 19, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 24, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 21, 2016 PREV
ASSIGNED TO LIE
Oct 18, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 4, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 4, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 4, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2016 CNEA
ASSIGNED TO EXAMINER
Sep 30, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 30, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 29, 2016 NWOS
NEW APPLICATION ENTERED
Jun 28, 2016 NWAP